✦ LIBER ✦

7106 Predictive and prognostic factors in a phase III study of pazopanib in patients with advanced renal cell carcinoma (RCC)

✍ Scribed by Sternberg, C.; Davis, I.; Wagstaff, J.; Hawkins, R.; Chen, M.; Ding, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-related quality of life in patien

✍ D. Cella; A.S. Pickard; M.S. Duh; A. Guerin; N. Mishagina; L. Antràs; M.P. Neary 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Re: Pazopanib in Locally Advanced or Met

✍ Taneja, Samir S. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

RANDOMISED PHASE III TRIAL OF THE MULTIK

✍ Escudier, B.; Szczylik, C.; Eisen, T.; Oudard, S.; Stadler, W.M.; Schwartz, B.; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

7130 Efficacy and safety of sorafenib in

✍ Bukowski, R.; Eisen, T.E.; Stadler, W.S.; Szczylik, C.S.; Oudard, O.S.; Siebels, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

49LBA Final results of a Phase II random

✍ P. Mulders; R. Hawkins; P. Nathan; I. de Jong; S. Osanto; E. Porfiri; A. Prother 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A randomised, double-blind phase III stu

✍ Sternberg, Cora N.; Hawkins, Robert E.; Wagstaff, John; Salman, Pamela; Mardiak, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB